A Phase 1, Two-part Study to Evaluate the Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of BMS-986369 and to Explore the Effect of Food on the Bioavailability of BMS-986369 in Healthy Participants
Latest Information Update: 17 Jul 2024
At a glance
- Drugs Golcadomide (Primary)
- Indications Follicular lymphoma
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
Most Recent Events
- 26 May 2023 Status changed from recruiting to completed.
- 05 Oct 2022 Planned End Date changed from 14 Nov 2022 to 30 Mar 2023.
- 05 Oct 2022 Planned primary completion date changed from 8 Nov 2022 to 30 Mar 2023.